Chemotherapy Exposure and outcomes of Chronic Lymphoid Leukemia Patients
Journal Title: Journal of Clinical Intensive Care and Medicine - Year 2017, Vol 2, Issue 1
Abstract
This study describes chemotherapy exposure, healthcare utilization, overall survival (OS) and progression-free survival (PFS) among patients diagnosed with chronic lymphoid leukemia (CLL). Newly diagnosed CLL patients who received chemotherapy were selected from the Eindhoven Cancer Registry between 1998-2011, linked on a patient-level to the PHARMO Database Network including data on in- and out-patient drug dispensings, hospitalizations and clinical laboratory measurements. Chemotherapy was classified in regimens of use based on chemotherapy combinations. OS and PFS were determined after diagnosis and after chemotherapy. Healthcare utilization was assessed in the year before diagnosis and in the year after chemotherapy.
Authors and Affiliations
Josephina G Kuiper, Patience Musingarimi, Christoph Tapprich, Fernie JA Penning- van Beest, Maren Gaudig
Keywords
Related Articles
- EP ID EP556933
- DOI 10.29328/journal.jcicm.1001006
- Views 43
- Downloads 0
Phenibut Overdose in Combination with Fasoracetam: Emerging Drugs of Abuse
The widespread availability of non-traditional dietary supplements and pharmacologically active substances via the Internet continues to introduce mechanisms for inadvertent toxidromes not commonly seen. Consumers are vi...
Evaluation of Desmin, α-SMA and hTERT expression in pulmonary fibrosis and lung cancer
Background: Pulmonary fibrosis is a clinical problem with an enigmatic etiology with no effective therapy. Current therapies for lung fibrosis are ineffective for progression of lung fibrosis and preventing respiratory f...
Dependence of the results of treatment of acute pneumonia on the doctrine of the disease
Treatment of various inflammatory processes, including acute pneumonia(АP), over the past decades is identical and does not reflect the specifics of a particular disease. The basis of such treatment is «antibiotics alone...
Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function
Observing relevant biomedical literature we have see that clinical pharmacist play a crucial role in ICU settings with reducing in mortality rate and improving some clinical outcomes.
Critical Management of Status Epilepticus
Seizure is clinical manifestation of sudden disruption of the normal electrical activity of cortical neurons. The brain electrical activity is periodically disturbed, alteration in neural cell integrity, increase in firi...